PubMed Health⌕ Search

Biomedical subjects

D Stropova

Publications and source records attributed to D Stropova.

21 records · Page 2Linked to original sources

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.

In the present study, we replaced the third extracellular loop of the human delta-opioid receptor with that of the human mu-opioid receptor. A modified polymerase chain reaction overlap extension method was used to achieve the exact splicing in the chimera to show the importance of the extracellular loop in ligand binding without interference from transmembrane substitutions. The replacement of the third extracellular loop did not alter the affinity of [3H]diprenorphine but caused a dramatic decrease in the affinity of both the delta-selective peptide agonists cyclo[D-Pen2,4'Cl-Phe4,D-Pen5]enkephalin and deltorphin II and the delta-selective nonpeptide agonists SNC 121 and (-)TAN 67. The affinities of the mu-selective peptide agonist [D-Ala2-MePhe4-Gly-ol5]enkephalin and the mu-preferring nonpeptide agonist morphine were not affected. Site-directed mutagenesis studies show that the mechanism of ligand recognition might be different for each structural class of opioid ligands.

Amino Acid Sequence↗

The role of the Val353 residue in antagonist binding to rat CCK-B receptors.

The Val353 residue of the rat cholecystokinin-B (CCK-B) receptor was mutated to Leu to test whether this residue is part of a binding site for antagonists having different chemical structures. The agonist radioligand [3H]SNF 8702 showed similar affinity for both wild-type and mutant receptors. Mutation of the CCK-B receptor reversed the order of affinities for the asperlicin derivatives from L-365,260 > devazepide (wild-type) to devazepide > L-365,260 (mutant) but had no effect on the affinity of the peptoid CCK-B receptor antagonist Cam-1028. The results show that Val353 is not part of a general CCK-B receptor antagonist recognition site and that Cam-1028 is recognized at a receptor site distinct from that binding asperlicin derivatives.

Amino Acids↗